Vanda Pharmaceuticals (VNDA) Shares Outstanding (Entity) (2010 - 2026)

Vanda Pharmaceuticals (VNDA) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Vanda Pharmaceuticals 315.57 Mn 145.54 Mn 46.97 Mn 60.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 60.45 Mn
Mar 31, 2026 60.14 Mn
Dec 31, 2025 59.10 Mn
Sep 30, 2025 59.10 Mn
Jun 30, 2025 59.08 Mn
Mar 31, 2025 58.93 Mn
Dec 31, 2024 58.31 Mn
Sep 30, 2024 58.31 Mn
Jun 30, 2024 58.29 Mn
Mar 31, 2024 58.20 Mn
Dec 31, 2023 57.53 Mn
Sep 30, 2023 57.53 Mn
Jun 30, 2023 57.50 Mn
Mar 31, 2023 57.44 Mn
Dec 31, 2022 56.78 Mn
Sep 30, 2022 56.59 Mn
Jun 30, 2022 56.55 Mn
Mar 31, 2022 56.49 Mn
Dec 31, 2021 55.90 Mn
Sep 30, 2021 55.71 Mn